I can’t PM, so feel free to email me but…
Post# of 155561
(Total Views: 716)
Posted On: 07/30/2025 1:08:21 AM
I can’t PM, so feel free to email me but…
Yes…. in theory, Leronlimab (LL) could be made available through Right to Try or Compassionate Use, but it depends on the company’s willingness, the FDA’s process, and physician support.
If CytoDyn chooses to participate, and the patient meets criteria, it’s possible. But…
Here’s What Matters:
1. Right to Try (RTT):
• Federal law allows terminally ill patients to request investigational drugs outside of trials.
• The company must agree to provide it.
• It bypasses some FDA barriers but not all.
2. Expanded Access (Compassionate Use):
• Requires a physician’s formal request.
• Needs CytoDyn’s consent and an FDA approval (usually granted fast in critical cases).
• IRB approval may be needed, but often streamlined.
Your Best Course of Action:
• Get a doctor on board first, one willing to sign the paperwork.
• Reach out to CytoDyn’s clinical or medical team (use official channels, not investor boards).
• Clearly outline the case, and ask if they’re open to compassionate use.
• Be respectful but direct emphasize the medical crisis and patient history.
My Personal Word
This woman sounds like the exact kind of person these laws were meant for. Don’t give up!!!!
And if CytoDyn wants to honor the healing they’ve claimed to carry this is a moment to step up and prove it.
You’re not asking for charity.
You’re asking for a chance.
Yes…. in theory, Leronlimab (LL) could be made available through Right to Try or Compassionate Use, but it depends on the company’s willingness, the FDA’s process, and physician support.
If CytoDyn chooses to participate, and the patient meets criteria, it’s possible. But…
Here’s What Matters:
1. Right to Try (RTT):
• Federal law allows terminally ill patients to request investigational drugs outside of trials.
• The company must agree to provide it.
• It bypasses some FDA barriers but not all.
2. Expanded Access (Compassionate Use):
• Requires a physician’s formal request.
• Needs CytoDyn’s consent and an FDA approval (usually granted fast in critical cases).
• IRB approval may be needed, but often streamlined.
Your Best Course of Action:
• Get a doctor on board first, one willing to sign the paperwork.
• Reach out to CytoDyn’s clinical or medical team (use official channels, not investor boards).
• Clearly outline the case, and ask if they’re open to compassionate use.
• Be respectful but direct emphasize the medical crisis and patient history.
My Personal Word
This woman sounds like the exact kind of person these laws were meant for. Don’t give up!!!!
And if CytoDyn wants to honor the healing they’ve claimed to carry this is a moment to step up and prove it.
You’re not asking for charity.
You’re asking for a chance.
(20)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com style="color:red">
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com